Egyszerű nézet

dc.contributor.author Feher J,
dc.contributor.author Lengyel, Gabriella
dc.contributor.author Blázovics, Anna
dc.date.accessioned 2018-01-04T22:13:24Z
dc.date.available 2018-01-04T22:13:24Z
dc.date.issued 1998
dc.identifier 0032240233
dc.identifier.citation pagination=38-46; journalVolume=33; journalIssueNumber=Suppl: 228; journalTitle=SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY SUPPLEMENT;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/4526
dc.description.abstract Oxidative stress plays an important role in the pathogenesis of toxic liver diseases and of other hepatic alterations. We summarize the pathomechanism of free radical reactions in liver diseases and the results of experimental and clinical observations. Most of the hepatoprotective drugs belong in the group of free-radical scavengers, their mechanism of action involving membrane stabilization, neutralization of free radicals and immunomodulation. We demonstrate the effects of the different drugs used in the therapy of liver diseases in animal experiments and in human clinicopharmacological studies. The scavenger effect of these drugs has been demonstrated in the subcellular fractions of liver cells in animal experiments. In vitro incubation with some hepatoprotective drugs inhibit lectin-induced lymphocyte transformation while others decrease the antibody-dependent, spontaneous, and lectin-induced lymphocytotoxicity. Dihydroquinolin-type antioxidants and silymarin enhanced the superoxide dismutase activity of erythrocytes and lymphocytes. In addition, in a 6-month double-blind clinical trial of patients with chronic alcoholic liver disease, we studied the effects of silymarin therapy on liver function tests, on the parameters characterizing the oxidative stress and immune reaction, on serum procollagen III peptide level, and on liver histology. A wide range of methods was used. The silymarin preparate corrected the altered immune reaction and the decreased superoxide-dismutase activity of erythrocytes and lymphocytes in patients with alcoholic liver cirrhosis. The results indicate that these drugs exert hepatoprotective activity and can improve liver functions in alcoholic patients and in toxic liver diseases. We found a correlation between the bilirubin concentration and lipid peroxidation in cases with toxic liver and biliary tract diseases, and assume that there are two kinds of bilirubin, an antioxidant and a prooxidant form, on the basis of diene conjugates in the bile.
dc.relation.ispartof urn:issn:0085-5928
dc.title Oxidative stress in the liver and biliary tract diseases.
dc.type Journal Article
dc.date.updated 2017-10-17T09:18:20Z
dc.language.rfc3066 en
dc.identifier.mtmt 1399948
dc.identifier.wos 000077456400006
dc.identifier.pubmed 9867111
dc.contributor.department SE/AOK/K/II. Sz. Belgyógyászati Klinika
dc.contributor.institution Semmelweis Egyetem
dc.mtmt.swordnote Conference: Annual Meeting of the Hungarian-Society-of-Gastroenterology Location: HUNGARY Date: 1997 Sponsor(s): Hungarian Soc Gastroenterol


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet